[ Price : $8.95]
FDA accepts a BioCryst NDA for Orladeyo to be used in pediatric patients with hereditary angioedema.[ Price : $8.95]
Merck's Keytruda meets a Phase 3 clinical trial primary endpoint of progression-free survival for treating patients with platinum-...[ Price : $8.95]
FDA approves an Incyte supplemental BLA for Zynyz (retifanlimab-dlwr) in combination with carboplatin and paclitaxel for the first...[ Price : $8.95]
FDA warns Chinas Shantou S.E.Z. Baojie Industry about CGMP violations in its production of finished drugs, some of which may be re...[ Price : $8.95]
Biotech executives, investors, and consultants say some companies are moving early clinical trials overseas due to fears of instab...[ Price : $8.95]
FDA approves a Merck NDA for Welireg (belzutifan), an oral drug for treating adults and pediatric patients aged 12 and older with ...[ Price : $8.95]
FDA gives AbbVie accelerated approval for its Emrelis (telisotuzumab vedotin-tllv) for treating certain adult patients with locall...[ Price : $8.95]
FDA clears a BrightHeart 510(k) for the B-Right Views, an artificial intelligence-powered tool that automatically detects the stan...